Biologists have found an explanation for the increase in intraocular pressure in glaucoma and a promising therapeutic option to rejuvenate the eye. Researchers at the Center for Vascular Research, ...

Glaucoma is the second most common cause of blindness in the United States and worldwide. [1,2] It is a progressive optic neuropathy characterized by nerve atrophy and loss of retinal ganglion cells.

A University of Missouri researcher has discovered biomarkers in the eye that could help identify and treat glaucoma, a leading cause of irreversible blindness among older adults. Pawan Singh, an ...

Acute angle-closure glaucoma is a rare but serious type of glaucoma. This condition occurs when drainage canals in the eye become blocked. If a person does not get treatment, acute angle-closure ...

Leveraging Northway Biotech’s 20+ years of CDMO expertise, Diorasis Therapeutics is advancing DT003, a single-dose AAV gene therapy for glaucoma. As part of the collaboration, Northway Biotech will ...